Safety of Ocrelizumab in Relapsing and Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Neurology 2021 Oct 19;97(16)e1546-e1559, SL Hauser, L Kappos, X Montalban, L Craveiro, C Chognot, R Hughes, H Koendgen, N Pasquarelli, A Pradhan, K Prajapati, JS WolinskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.